PMID: 8603016Feb 1, 1996Paper

Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation

British Journal of Haematology
M L NierodzikS Karpatkin

Abstract

Thrombin-treated tumour cells enhance their adhesion to platelets, fibronectin and von Willebrand factor in vitro, and enhanced their pulmonary metastasis in mice in vivo. A unique seven transmembrane spanning thrombin receptor has recently been cloned which is activated following thrombin proteolysis of the N-terminal end of the receptor with exposure of a tethered ligand. An N-terminal 14-mer (SFLLRNPNKYEPF) or 6-mer (SFLLRN) of the tethered ligand can serve as a thrombin receptor activation peptide (TRAP) by mimicking the action of thrombin on platelets, endothelial cells and smooth muscle cells. We have examined six human tumour cell lines for their response to TRAP, for the presence of this thrombin receptor mRNA by RT-PCR, protein by immunoblot and for their in vitro and in vivo response to TRAP. All six cell lines contain the receptor mRNA, and when treated with 100 microM 6-mer TRAP or 1 u/ml thrombin increase their adhesion to platelets 2-3-fold. Four of the six cell lines undergo tyrosine phosphorylation within 30 s to 1 min after exposure to 6-mer TRAP or thrombin. Thus tumour cells respond to thrombin via activation of their seven transmembrane spanning thrombin receptor.

Citations

May 16, 2001·Biochemical and Biophysical Research Communications·M ZiegerR Kaufmann
Aug 21, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Sven DanckwardtAndreas E Kulozik
Mar 25, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Vladislava O MelnikovaMenashe Bar-Eli
Apr 17, 2009·Pigment Cell & Melanoma Research·Vladislava O Melnikova, Menashe Bar-Eli
Nov 13, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Shashank JainJerry Ware
Mar 8, 2005·Journal of Thrombosis and Haemostasis : JTH·M Nierodzik, S Karpatkin
Dec 23, 2004·Journal of Thrombosis and Haemostasis : JTH·S Karpatkin
Oct 3, 2003·Journal of Thrombosis and Haemostasis : JTH·M CauntS Karpatkin
Mar 27, 2004·Physiological Reviews·Valeria S Ossovskaya, Nigel W Bunnett
Nov 14, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·J C GiddingsM J Lewis
Apr 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Christopher D MajorPatricia Andrade-Gordon
Feb 9, 2008·Journal of Cellular Biochemistry·Ozge UluçkanKatherine Weilbaecher
Feb 23, 1999·British Journal of Cancer·K P HenriksonB T Pentecost
Sep 19, 2014·International Journal of Oncology·Tadayoshi OtsukiAkio Yamaguchi
Aug 1, 2012·Oncology Letters·Na HanLisong Teng
Jun 5, 1998·The American Journal of Physiology·O DéryN W Bunnett
Nov 30, 2011·Journal of Thrombosis and Haemostasis : JTH·B PsailaI Roberts
Aug 2, 2017·Cancer Metastasis Reviews·Argentina OrnelasSteven Millward
Apr 19, 2006·Cancer Research·Maresa CauntSimon Karpatkin
Jun 4, 2008·Cancer Research·Liang HuSimon Karpatkin
Feb 8, 2020·Thrombosis Research·Bo ZhangYu Hu
Sep 21, 2010·Bone·Jochen G SchneiderKatherine N Weilbaecher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.